Navigation Links
Update on FDA Advisory Committee Meeting on Liraglutide for the Treatment of Type 2 Diabetes
Date:4/2/2009

SILVER SPRING, Md., April 2 /PRNewswire-FirstCall/ -- Novo Nordisk today announced that the Endocrinologic and Metabolic Drugs Advisory Committee of the United States Food and Drug Administration (FDA) has finalized its discussions of questions related to liraglutide, a once-daily human GLP-1 analogue.

The Advisory Committee voted on questions related to the risk profile of liraglutide.

  • A majority of Advisory Committee members supported that appropriate evidence of cardiovascular safety had been provided to rule out excess cardiovascular risk of liraglutide relative to comparators.
  • While a majority of Advisory Committee members did not find that Novo Nordisk based on the available data had ruled out that the finding of C-cell tumours in rodents was not relevant to humans, the Advisory Committee was split on the FDA question related to whether the available data on C-cell tumours permitted approvability.
  • Finally, the Advisory Committee unanimously supported approvability of liraglutide with regard to risk of papillary thyroid cancer.

"We remain convinced that liraglutide has a positive benefit/risk profile and represents an important advance for people with type 2 diabetes. We will work closely with the FDA as it completes its review of our application to address the concerns expressed by members of the Advisory Committee," said Mads Krogsgaard Thomsen, executive vice president and chief science officer of Novo Nordisk.

The Advisory Committee reviewed data from 40 clinical studies involving more than 6,800 people with type 2 diabetes of which more than 4,600 were treated with liraglutide.

The timing of US launch of liraglutide will be determined after completion of the FDA's review of the application.

The outcome of the FDA Advisory Committee is not expected to significantly impact
'/>"/>

SOURCE Novo Nordisk
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Pharmos Issues Business Update on Dextofisopam Trial and Financing
2. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
3. Forest Laboratories, Inc. and Laboratorios Almirall, S.A. Provide an Update on the Aclidinium Bromide Clinical Development Program
4. MannKind Updates Status of NDA Submission for AFRESA
5. Keryx Biopharmaceuticals, Inc. Reports Updated Phase 1/2 Data on KRX-0401 (Perifosine) in Combination with Bortezomib (+/- Dexamethasone) at the 12th International Multiple Myeloma Meeting
6. BN ImmunoTherapeutics Updates on Phase I/II Studies With Breast Cancer Vaccine
7. Update of Long-Term Data on Brain Cancer Patients Receiving DCVax(R)-Brain Continues to Show Striking Improvements in Delay of Disease and Survival
8. Savient Provides Update on Pegloticase BLA
9. Synvista Therapeutics Announces Termination of Clinical Trials of Alagebrium and SYI-2074 and Provides Business Update
10. Impact Medical Solutions Announces Appointment of New Director and Corporate Update
11. Clinical Update - Debio 025 in Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... -- Foundation Health Care  (FDNH), which owns and operates hospitals ... it will present at the LD Micro Invitational Conference ... Boulevard Hotel, Los Angeles, CA. ... at 3:00pm and will also be available for ... LD Micro. For more information about the conference, please ...
(Date:5/27/2015)... , May 27, 2015  Genomic Health, Inc. (Nasdaq: ... Operating Officer and Chief Financial Officer, will present at the ... City on Monday, June 1 at 8:30 a.m. ... subsequently archived webcast of the presentation, go to the  Investor ... .  Please connect to the web site at least 15 ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... the "Research and Future Development Trend Forecast of ... At present, there are 35,600 dialysis centers ... ratio are large due to the different regional operating ... centers in other Asian countries are operated by state-owned ...
Breaking Medicine Technology:Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 2Genomic Health to Present at the Jefferies 2015 Global Healthcare Conference 3China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
... 19, 2011 ICAP Patent Brokerage , ... intellectual property brokerage and patent auction firm, is ... major medical device company. The available portfolios disclose ... control, high-intensity focused ultrasound (HIFU) energy, improved blood ...
... SAN DIEGO, Oct. 19, 2011 CareFusion (NYSE: ... following update regarding its recall of 128 EnVe™ ventilators affecting ... Class I recall. The voluntary recall only ... and therefore, has no affect on the company,s current product ...
Cached Medicine Technology:Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage 2Global Leader in Medical Technology Offers for Sale Seven Patent Portfolios Through ICAP Patent Brokerage 3CareFusion Initiates Class I Recall of EnVe Ventilators 2
(Date:5/27/2015)... May 27, 2015 SAN DIEGO, ... Gulfport Mississippi, is the first healthcare provider along ... to chronic care management (CCM). In partnership with ... is introducing RevUp, a new program that enables ... and increase monthly reimbursements. This new, user-friendly program ...
(Date:5/27/2015)... May 27, 2015 Coco Libre announced today ... able to reach for Organic Coconut Water to quench their ... be available at VIP areas, artist greenrooms, corporate skyboxes and ... at area hotels and on festival shuttle buses. , ... year,” said Noa Elan, Director of Strategic Partnerships for Latitude ...
(Date:5/27/2015)... 27, 2015 This is a ... of the Omega-3 industry. The report provides a ... applications and industry chain structure. The Omega-3 market ... development trends, competitive landscape analysis, and key regions ... Camanchaca Fishing Company, Seadragon Marine Oils, Norwegian Fish ...
(Date:5/27/2015)... With InnerVoice Communication App you will ... is not only heard but seen -- by a photograph ... image. This award-winning and affordable app takes full advantage of ... InnerVoice Sender app in conjunction with InnerVoice Communication ... remotely for no additional cost. , InnerVoice Sender ...
(Date:5/27/2015)... For a limited time, San Fernando ... discounts on facial fillers. Skin loses more than 2 percent ... This lost collagen can lead to thinning or sagging skin, ... Facial fillers are an excellent way to plump skin and ... to create a softer and more youthful appearance, without the ...
Breaking Medicine News(10 mins):Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 2Health News:Memorial Hospital Selects MD Revolution's Digital Health Platform to Deliver a New Form of Chronic Care Management 3Health News:Coco Libre Puts Organic Coconut Water on the Line-up at BottleRock Napa 2Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 2Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 3Health News:Newly Released: InnerVoice Sender App Ups the Ante in Communication Technology for Autism with Remote Prompting 4Health News:Dermatologist, Dr. Peyman Ghasri, is Now Offering Discounts on Facial Fillers 2
... Announced the Initiation of the Phase III ... to Treat Rheumatoid Arthritis., COPENHAGEN, Denmark, November 20 ... GSK) announced today the,initiation of the Phase III program ... commence with two studies,(GEN410/OFA110635 and GEN411/OFA110634) which will be ...
... November 20 With the recent,FDA approval of ... and follow-up of cancerous or other potentially malignant,lesions ... Technologies,succeeds in setting the trend in diagnostic oncology ... Lesion Management Solutions at the,93rd annual meeting of ...
... Nov. 16 For patients with,rheumatoid arthritis, combining one ... medications often works best to reduce joint,swelling or tenderness, ... for,Healthcare Research and Quality, part of the U.S. Department ... report will be posted on-line,Monday in the Annals of ...
... 19 If you or someone you know,has been ... or medical,personnel working with lung cancer patients, you won,t ... Advocacy Conference. The conference,co-presented by the American Lung Association ... be held Friday, Nov. 30, at the,Ritz-Carlton Dearborn. Medical ...
... healthy individuals, have made a key discovery in understanding ... and remain untreated by the bodys own natural defences. ... 23 November) by the Proceedings of the National Academy ... , Under normal circumstances, the immune system creates ...
... studies suggest , , MONDAY, Nov. 19 (HealthDay News) -- People ... and dementia as they age, two new studies suggest. ... pressure increased the risk of developing disabilities, such as not ... or bathe oneself. , "High blood pressure affects many ...
Cached Medicine News:Health News:Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 2Health News:Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 3Health News:Genmab and GlaxoSmithKline Initiate Ofatumumab Rheumatoid Arthritis Phase III Program 4Health News:MEDIAN Technologies Lesion Management Solutions Set the Trend in Diagnostic Oncology Imaging at RSNA 2007 2Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 2Health News:Combining Medications Often Best Strategy to Battle Rheumatoid Arthritis 3Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 2Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 3Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 4Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 5Health News:BREATHE Lung Cancer Conference, Nov. 30, Offers Medical and Patient Education, Advocacy and Survivor's Perspective 6Health News:New research helps explain how tumors go undetected by the body 2Health News:High Blood Pressure Linked to Disability, Dementia 2Health News:High Blood Pressure Linked to Disability, Dementia 3
... portable NEVA™ System is designed ... changes within the penis nocturnally. ... to monitor and record impedance ... changes in penile blood volume. ...
... designed for vascular labs already equipped ... Its primary use will be for ... cuff with air. Blood pressures ... - a proximal occluding cuff connected ...
... your patients come to you with ... they can understand. Then they want ... Rigidity Assessment System can you gather, ... rigidity and tumescence data...and provide the ...
... The table top design takes into ... and creates a flexible working environment for ... the alphamaxx can be matched exactly to ... top slide capability creates superior access for ...
Medicine Products: